34 news items found.
COVID-19 Belgian vaccination strategy: season 2024-2025
Report 9833
This report provides recommendations for the Belgian vaccination strategy against COVID-19 in season 2024-2025. The focus is on the efficacy and safety of vaccines adapted to the Omicron variant and vaccination of pregnant women in particular.
Vaccination against seasonal influenza
Report 9831
This advisory report deals with the vaccination against seasonal flu and determines which population groups should be given priority for vaccination.
Prevention against RSV disease in children
Report 9760
RSV (respiratory syncytial virus) is the leading cause of lower respiratory tract infections in babies under one year old. Every winter, it puts a huge strain on the healthcare system in Belgium. During 2024, two new preventive drugs will appear on the Belgian market to combat this virus...
Vaccination of persons at risk of meningococcal infection
Report 9759
Vaccination against meningococcal ACWY has been part of the basic vaccination schedule for children and adolescents since 2019. For certain risk groups, the SHC recommends the meningococcal group B vaccine, with booster doses for both vaccines depending on the group. This new advice provides an...
Vaccination against RSV (adults)
Report 9725
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on vaccination against RSV (adults).
Vaccination against dengue
Report 9739
Since March 2023, the vaccine Qdenga® is available on the Belgian market. This vaccine reduces the risk of a severe course of dengue infection. The vaccine may be administered to children as young as 6 years old. Dengvaxia® is not available in Belgium and is not recommended to travellers.
Pneumococcal vaccination in children and adolescents
Report 9746
Given the evolution of our epidemiology and the predominance of non-vaccine serotypes (non-PCV15) in Belgium, the effect of PCV13 or PCV15 vaccines can be expected to be comparable in the target group.
On this basis, the SHC currently recommends, without preference, PCV13 or PCV15 over PCV10.
On this basis, the SHC currently recommends, without preference, PCV13 or PCV15 over PCV10.
Vaccination against COVID-19 for infants and children
Report 9722
In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations on mRNA COVID-19 vaccination for infants and children (preschool - 6 months to 5 years old) in Belgium. This report aims at providing the Belgian...
Vaccination against pneumococcal disease (adults)
Report 9674
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on vaccination against pneumococcal disease for adults.
Vaccination strategy against Monkeypox (revision, August 2022)
Report 9727
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides an update of the recommendations regarding the vaccination strategy against Monkeypox in the context of the European multi-country outbreak in May 2022. This ...
Vaccination against Herpes Zoster
Report 9684
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the prevention of herpes zoster infections in the Belgian population.
COVID-19 vaccination: Autumn / Winter season 2022-2023
Report 9721
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on COVID-19 vaccination during the autumn/winter season of 2022-2023 for the Belgian population.
Second booster vaccination against COVID-19
Report 9706
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for a second booster vaccination against COVID-19 for the adult population.
Booster vaccination for children and adolescents
Report 9693
In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations on the need for a booster vaccination against COVID-19 for children and adolescents aged 12-17 years in Belgium.
Booster vaccination against COVID-19 for immunocompromised patients
Report 9691
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for booster vaccination against COVID-19 for immunocompromised individuals.
Vaccination against COVID-19 of children aged 5-11
Report 9680
In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations regarding the pediatric vaccination against COVID-19 of children aged 5 to 11 years.
Booster vaccination against COVID-19
Report 9683
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for booster vaccination against COVID-19.
Booster dose after Janssen vaccine
Report 9677
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for a booster dose with an mRNA COVID-19 vaccine for individuals who received the Janssen (1 dose) vaccine for their primary...
Booster dose for healthcare workers
Report 9679
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on vaccination against COVID-19 for healthcare workers.
Mandatory vaccination of healthcare personnel
Report 9671
In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on mandatory vaccination against COVID-19 for the healthcare sector.